Download PDF
1 / Pages

Other users also viewed these articles

Prevalence and Determinants of COPD in Spain: EPISCAN II Joan B. Soriano; Inmaculada Alfageme; Marc Miravitlles; Pilar de Lucas; Juan José Soler-Cataluña; Francisco García-Río; Ciro Casanova; José Miguel Rodríguez González-Moro; Borja G. Cosío; Guadalupe Sánchez; Julio Ancochea;
Arch Bronconeumol. 2021;57:61-9
Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017 Elena García Castillo; Tamara Alonso Pérez; Adrián Peláez; Patricia Pérez González; Marc Miravitlles; Inmaculada Alfageme; Ciro Casanova; Borja G. Cosío; Pilar de Lucas; Francisco García-Río; José Miguel Rodríguez González-Moro; Juan José Soler-Cataluña; Guadalupe Sánchez; Joan B. Soriano; Julio Ancochea;
Arch Bronconeumol. 2023;59:142-51
[Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial Carmen Rodríguez; Aurora Solier; Marta Marín; Andrés Tenes; Diego Durán; Ana Retegui; Alfonso Muriel; Remedios Otero; Manuel Monreal; David Jiménez;
Arch Bronconeumol. 2022;58:T412-7